Kidney Cancer Awareness Month
Kidney cancer is among the most common cancers in the United States, with nearly 73,750 new diagnoses and 14,830 deaths in 2020, according to federal estimates.
Also known as renal cancer, kidney cancer is often treated with surgery to remove all or part of the affected organ. Some patients may be given chemotherapy or radiation therapy after surgery to destroy unseen cancer cells that may remain following the procedure. For a few patients, most commonly those with advanced disease, treatment may include a molecularly targeted therapeutic or an immunotherapeutic.
Smoking is a risk factor for kidney cancer, as is misuse of certain pain medicines, including over-the-counter drugs. In addition, certain genetic conditions, such as von Hippel-Lindau disease, increase a person’s risk of developing kidney cancer.
March is Kidney Cancer Awareness Month.
Since 2012, the AACR has partnered with Kure It Cancer Research to support innovative translational kidney cancer research. Read some of the highlights of progress made by researchers supported by the AACR-Kure It partnership.
One AACR-Kure It funded researcher, W. Kimryn Rathmell, MD, PhD, discusses how such grant funding partnerships provide critical support for cancer researchers.